Want to see HIND full AI Analyst Report?
HIND Stock Chart & Stats
$2.06
$0.00(0.00%)
At close: 4:00 PM EDT
$2.06
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.75 - $12.00
Previous CloseN/A
Volume1.31K
Average Volume (3M)16.09K
Market Cap
$16.00M
Enterprise Value$3.50M
Total Cash (Recent Filing)$7.89M
Total Debt (Recent Filing)$17.31K
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Nov 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-29.90
Shares Outstanding7,018,528
10 Day Avg. Volume12,409
30 Day Avg. Volume16,085
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.04
Price to Sales (P/S)23.26
P/FCF Ratio-1.98
Enterprise Value/Market Cap0.22
Enterprise Value/Revenue26.99
Enterprise Value/Gross Profit58.05
Enterprise Value/Ebitda-0.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.71
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageLow recent leverage reduces immediate balance-sheet strain and may preserve flexibility while the company addresses operating challenges. This is a relative strength, although continued losses could still require external financing or equity issuance.
Positive Gross MarginA positive gross margin indicates the underlying products or services generate revenue above direct costs. If revenue stabilizes, this provides a foundation for operating improvement, though substantial operating expenses currently prevent the margin from translating into profitability.
Moderating Cash BurnImproving free cash flow relative to the prior year suggests some moderation in cash burn and could extend financial runway. However, cash flow remains negative, so this is an early improvement rather than evidence of self-sustaining cash generation.
Bears Say
Severe Revenue DeclineThe steep revenue contraction signals major deterioration in commercial traction, product demand, or business scale. A smaller revenue base also makes fixed costs harder to absorb and materially increases uncertainty about the company’s ability to rebuild a sustainable operating platform.
Persistent UnprofitabilityDeep and recurring losses show that the company has not demonstrated a sustainable path to earnings. Continued operating deficits can constrain investment, weaken equity value, and require additional financing unless revenue growth and cost discipline improve materially.
Ongoing Cash BurnPersistent negative operating and free cash flow means the business is not funding itself through operations. If the condition continues, reliance on external capital may increase, creating funding, dilution, and execution risks despite the company’s relatively low current leverage.
Vyome Holdings News
HIND FAQ
What was Vyome Holdings’s price range in the past 12 months?
Vyome Holdings lowest stock price was $1.75 and its highest was $12.00 in the past 12 months.
What is Vyome Holdings’s market cap?
Vyome Holdings’s market cap is $16.00M.
When is Vyome Holdings’s upcoming earnings report date?
Vyome Holdings’s upcoming earnings report date is Nov 24, 2026 which is in 93 days.
How were Vyome Holdings’s earnings last quarter?
Vyome Holdings released its earnings results on May 28, 2026. The company reported -$0.15 earnings per share for the quarter, the consensus estimate of -$0.15 by $0.
Is Vyome Holdings overvalued?
According to Wall Street analysts Vyome Holdings’s price is currently Overvalued.
Does Vyome Holdings pay dividends?
Vyome Holdings does not currently pay dividends.
What is Vyome Holdings’s EPS estimate?
Vyome Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyome Holdings have?
Vyome Holdings has 7,018,528 shares outstanding.
What happened to Vyome Holdings’s price movement after its last earnings report?
Vyome Holdings reported an EPS of -$0.15 in its last earnings report, expectations of -$0.15. Following the earnings report the stock price went up 4.911%.
Which hedge fund is a major shareholder of Vyome Holdings?
Currently, no hedge funds are holding shares in HIND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vyome Holdings
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Technical Analysis
Scinai Immunotherapeutics
―
Collplant Holdings
―
Dermata Therapeutics
―
Azitra Inc
―
Polyrizon Ltd.
―
Ownership Overview
6.49% Insiders
0.36% Mutual Funds
― Other Institutional Investors
93.01% Public Companies and
Individual Investors